Comparison of Dopamine and Norepinephrine in the Treatment of Shock
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Both dopamine and norepinephrine are recommended as first-line vasopressor agents in the treatment of shock. There is a continuing controversy about whether one agent is superior to the other. METHODS: In this multicenter, randomized trial, we assigned patients with shock to receive either dopamine or norepinephrine as first-line vasopressor therapy to restore and maintain blood pressure. When blood pressure could not be maintained with a dose of 20 microg per kilogram of body weight per minute for dopamine or a dose of 0.19 microg per kilogram per minute for norepinephrine, open-label norepinephrine, epinephrine, or vasopressin could be added. The primary outcome was the rate of death at 28 days after randomization; secondary end points included the number of days without need for organ support and the occurrence of adverse events. RESULTS: The trial included 1679 patients, of whom 858 were assigned to dopamine and 821 to norepinephrine. The baseline characteristics of the groups were similar. There was no significant between-group difference in the rate of death at 28 days (52.5% in the dopamine group and 48.5% in the norepinephrine group; odds ratio with dopamine, 1.17; 95% confidence interval, 0.97 to 1.42; P=0.10). However, there were more arrhythmic events among the patients treated with dopamine than among those treated with norepinephrine (207 events [24.1%] vs. 102 events [12.4%], P<0.001). A subgroup analysis showed that dopamine, as compared with norepinephrine, was associated with an increased rate of death at 28 days among the 280 patients with cardiogenic shock but not among the 1044 patients with septic shock or the 263 with hypovolemic shock (P=0.03 for cardiogenic shock, P=0.19 for septic shock, and P=0.84 for hypovolemic shock, in Kaplan-Meier analyses). CONCLUSIONS: Although there was no significant difference in the rate of death between patients with shock who were treated with dopamine as the first-line vasopressor agent and those who were treated with norepinephrine, the use of dopamine was associated with a greater number of adverse events. (ClinicalTrials.gov number, NCT00314704.)
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Dopamine (DA) is a neurotransmitter in the catechol family, which is often used as first-line vasoactive drug in patients with septic shock (43).”
From Dopamine Is a Siderophore-Like Iron Chelator That Promotes Salmonella enterica Serovar Typhimurium Virulence in Mice (2019) · cites this paper as [43]
Citations
Cites
APACHE II: A severity of disease classification system
KNAUS, W. A., DRAPER, E. A., WAGNER, D. P., & ZIMMERMAN, J. E. (1985) · Critical Care Medicine · doi:10.1097/00003246-198510000-00009 · Cited by 13,664
APACHE II-A Severity of Disease Classification System: Reply
Knaus, W. A., Draper, E. A., Wagner, D. P., & Zimmerman, J. E. (1986) · Critical Care Medicine · doi:10.1097/00003246-198608000-00028 · Cited by 13,376
Vincent, J. L., Moreno, R., Takala, J., Willatts, S., De Mendonça, A., Bruining, H., Reinhart, C. K., Suter, P. M., & Thijs, L. G. (1996) · Intensive Care Medicine · doi:10.1007/bf01709751 · Cited by 11,674
Self-citationWriting Committee Members, Antman, E. M., Anbe, D. T., Armstrong, P. W., Bates, E. R., Green, L. A., Hand, M., Hochman, J. S., Krumholz, H. M., Kushner, F. G., et al. (2004) · Circulation · doi:10.1161/01.cir.0000134791.68010.fa · Cited by 8,356
Dellinger, R. P., Levy, M. M., Carlet, J. M., Bion, J., Parker, M. M., Jaeschke, R., Reinhart, K., Angus, D. C., Brun-Buisson, C., Beale, R., et al. (2008) · Intensive Care Medicine · doi:10.1007/s00134-007-0934-2 · Cited by 6,772
Self-citationCDC definitions for nosocomial infections, 1988
Garner, J. S., Jarvis, W. R., Emori, T. G., Horan, T. C., & Hughes, J. M. (1988) · American Journal of Infection Control · doi:10.1016/0196-6553(88)90053-3 · Cited by 5,672
CDC definitions for nosocomial infections
Yangco, B. G. (1989) · American Journal of Infection Control · doi:10.1016/s0196-6553(89)80013-6 · Cited by 3,770
Annane, D. (2002) · JAMA · doi:10.1001/jama.288.7.862 · Cited by 3,087
Treating Patients with Severe Sepsis
Wheeler, A. P., & Bernard, G. R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901213400307 · Cited by 992
Current Epidemiology of Septic Shock: The CUB-Réa Network
Annane, D., Aegerter, P., Jars-Guincestre, M. C., & Guidet, B. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2201087 · Cited by 637
Research works printed but not linked: 1
- Mullner M, 2004, Cochrane Database Syst Rev, 3, CD003709
Cited by
Items 601–700 of 1,000
Shim, J., Kim, K.-S., Couture, P., Denault, A. Y., Kwak, Y. L., Yoo, K., & Youn, Y. (2023) · Korean Journal of Anesthesiology · doi:10.4097/kja.23103 · Cited by 23
“Dopamine should be avoided because of its arrhythmogenic tendency and negative influence on outcomes [36,37], while the use of norepinephrine with vasopressin in an additive manner has been shown to be a useful strategy [38].”
Tosh, D., Janowsky, A., Eshleman, A., Warnick, E., Gao, Z.-G., Chen, Z.-M., Gizewski, E. T., Auchampach, J., Salvemini, D., & Jacobson, K. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00141 · Cited by 20
Shin, D. G., Kang, M.-K., Seo, Y. B., Choi, J., Choi, S. Y., Choi, S., Cho, J. R., & Lee, N. (2020) · PLoS ONE · doi:10.1371/journal.pone.0229563 · Cited by 23
“Norepinephrine is the first choice recommended by the guideline, while the use of dobutamine and dopamine is recommended only for selected patients due to the associated adverse events [7].”
BackgroundMethodBlood pressure targets and management during post-cardiac arrest care
Skrifvars, M. B., Ameloot, K., & Åneman, A. (2023) · Resuscitation · doi:10.1016/j.resuscitation.2023.109886 · Cited by 23
Asher, E., Karameh, H., Nassar, H., Yosefy, C., Marmor, D. B., Perel, N., Taha, L., Tabi, M., Braver, O., Shuvy, M., et al. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12175734 · Cited by 23
Wayland, J., Teixeira, J. P., & Nielsen, N. D. (2024) · Anaesthesia & intensive care medicine · doi:10.1016/j.mpaic.2024.06.010 · Cited by 23
The Interface Between Monitoring and Physiology at the Bedside
Bose, E. L., Hravnak, M., & Pinsky, M. R. (2014) · Critical Care Clinics · doi:10.1016/j.ccc.2014.08.001 · Cited by 23
Emergency Medicine Pharmacists and Sepsis Management
Weant, K. A., & Baker, S. N. (2012) · Journal of Pharmacy Practice · doi:10.1177/0897190012467211 · Cited by 23
“Studies have shown dopamine to increase the risk of sinus tachycardia and arrhythmias in patients with septic shock and increase the 28-day mortality in those with cardiogenic shock.(20,21) The presence of a clinical EM pharmacist at the Figure 4.”
BackgroundCurrent management of sepsis in critically ill adult patients
Vincent, J., Serrano, E. C., & Dimoula, A. (2011) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.11.65 · Cited by 23
Self-citationTranslational research: what does it mean, what has it delivered and what might it deliver?
Proudfoot, A. G., McAuley, D. F., Hind, M. D., & Griffiths, M. (2011) · Current Opinion in Critical Care · doi:10.1097/mcc.0b013e32834a4b19 · Cited by 23
On the right side of the heart: Medical and mechanical support of the failing right ventricle
de Asua, I., & Rosenberg, A. (2017) · Journal of the Intensive Care Society · doi:10.1177/1751143716684357 · Cited by 23
“The post-hoc analysis of patients the cardiogenic shock sub-group in the SOAP II study found a slight survival benefit for noradrenaline over dopamine.(28) Due to its adverse effects on multiple endocrine axis and its tendency to induce tachy-arrhythmias, dopamine is now rarely used as a first-line inotrope.”
MethodVasodilatory shock in the ICU and the role of angiotensin II
Wakefield, B. J., Sacha, G. L., & Khanna, A. K. (2018) · Current Opinion in Critical Care · doi:10.1097/mcc.0000000000000517 · Cited by 23
Allen, J. M., Feild, C. J., Shoulders, B. R., & Voils, S. A. (2018) · Annals of Pharmacotherapy · doi:10.1177/1060028018812940 · Cited by 23
Puskarich, M. A., McHugh, C. E., Flott, T. L., Karnovsky, A., Jones, A. E., & Stringer, K. A. (2020) · Shock · doi:10.1097/shk.0000000000001687 · Cited by 23
Presence of Preexisting Antibodies MEDIATES SURVIVAL in Sepsis
Moitra, R., Beal, D. R., Belikoff, B. G., & Remick, D. G. (2011) · Shock · doi:10.1097/shk.0b013e3182356f3e · Cited by 23
“The CLP model mimics the clinical scenario where even with optimal treatment some patients die, whereas others survive (20).”
Resuscitating the Critically Ill Geriatric Emergency Department Patient
Khoujah, D., Martinelli, A. N., & Winters, M. E. (2019) · Emergency Medicine Clinics of North America · doi:10.1016/j.emc.2019.04.002 · Cited by 23
Co, I. N., & Gunnerson, K. J. (2019) · Emergency Medicine Clinics of North America · doi:10.1016/j.emc.2019.04.006 · Cited by 23
Ramakrishna, H., & Morozowich, S. T. (2015) · Annals of Cardiac Anaesthesia · doi:10.4103/0971-9784.166464 · Cited by 23
“concentrations in patients receiving the same dose, and recent study demonstrating a higher incidence of arrhythmia and higher mortality in cardiogenic[102] and septic shock.”
ResultThiele, H., Schuler, G. C., Neumann, F., Hausleiter, J., Olbrich, H., Schwarz, B., Hennersdorf, M., Empen, K., Fuernau, G. F., Desch, S., et al. (2015) · American Heart Journal · doi:10.1016/j.ahj.2015.01.009 · Cited by 23
Vasoplegia Syndrome After Cardiac Surgery
Castagna, F., Mehra, M. R., Nabzdyk, C. S., & Givertz, M. M. (2025) · JACC Heart Failure · doi:10.1016/j.jchf.2025.02.028 · Cited by 22
Yao, L., Rey, D. A., Bulgarelli, L., Kast, R. E., Osborn, J., Ark, E. V., Fang, L. T., Lau, B., Lam, H. Y. K., Teixeira, L. M., et al. (2022) · Shock · doi:10.1097/shk.0000000000001910 · Cited by 22
Hyun, J., Cho, J. Y., Youn, J., Kim, D., Cho, D., Park, S. M., Jung, M., Cho, H., Park, S., Choi, J., et al. (2023) · International Journal of Heart Failure · doi:10.36628/ijhf.2023.0019 · Cited by 22
A Clinical Review of Vasopressors in Emergency Medicine
Stampfl, M. J., & DeBlieux, P. M. C. (2024) · Journal of Emergency Medicine · doi:10.1016/j.jemermed.2024.03.004 · Cited by 22
Initial fluid resuscitation of patients with septic shock in the intensive care unit
Carlsen, S., Perner, A., & for the East Danish Septic Shock Cohort Investigators (2011) · Acta Anaesthesiologica Scandinavica · doi:10.1111/j.1399-6576.2011.02399.x · Cited by 22
“1 mg/kg/min noradrenaline.(10) The converted dose of dopamine was added to any noradrenaline dose and referred to as the maximum vasopressor dose.”
MethodChen, Y., Wu, V., Huang, W., Yeh, Y., Wu, K., Huang, C., Wu, K., Fang, J., Wu, C., NSARF, T., et al. (2018) · Journal of Clinical Medicine · doi:10.3390/jcm7090274 · Cited by 22
“The result was similar in septic shock and hypovolemic shock, except in cardiogenic shock when the researchers conducted subgroup analysis [40].”
ResultCost-effectiveness of second-line vasopressors for the treatment of septic shock
Lam, S. W., Barreto, E. F., Scott, R. A., KASHANI, K. B., Khanna, A. K., & Bauer, S. R. (2019) · Journal of Critical Care · doi:10.1016/j.jcrc.2019.10.005 · Cited by 23
Scurt, F. G., Bose, K., Canbay, A. E., Mertens, P. R., & Chatzikyrkou, C. (2020) · Zeitschrift für Gastroenterologie · doi:10.1055/a-1255-3413 · Cited by 22
Venkataraman, S., Bhardwaj, A., Belford, P. M., Morris, B. N., Zhao, D. X.-M., & Vallabhajosyula, S. (2022) · Medicina · doi:10.3390/medicina58020215 · Cited by 22
“Although patients on norepinephrine were found to have fewer arrhythmias than those on dopamine, there are no studies to compare these effects in those with myocarditis [25].”
ResultVadiei, N., Daley, M. J., Murthy, M. S., & Shuman, C. (2016) · Annals of Pharmacotherapy · doi:10.1177/1060028016682030 · Cited by 22
“17 Time until additional agent discontinued (hours), median (IQR) 29 (12-50) 29 (8-92) 0.”
BackgroundCurrent Status of Cardiovascular Anesthesia in China
Lu, J., Wang, W., Cheng, W., Chen, L., Huang, J. J., Ethridge, C. A., & Huang, J. (2017) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000002051 · Cited by 22
Haemodynamic management of septic shock
Kotani, Y., Ryan, N., Udy, A. A., & Fujii, T. (2025) · Burns & Trauma · doi:10.1093/burnst/tkae081 · Cited by 22
“Indeed, when compared to noradrenaline, dopamine increases not only the risk of arrhythmias [5] but also that of death [33].”
Common Sense Approach to Managing Sepsis
Perner, A., Holst, L. B., Haase, N., Hjortrup, P. B., & Møller, M. H. (2017) · Critical Care Clinics · doi:10.1016/j.ccc.2017.08.009 · Cited by 21
Burstein, B. J., Vallabhajosyula, S., Ternus, B. W., Murphree, D. H., Barsness, G. W., KASHANI, K. B., & Jentzer, J. C. (2021) · Shock · doi:10.1097/shk.0000000000001767 · Cited by 21
Liu, S., Meng, Q., Xu, Y., & Zhou, J. (2021) · Gastroenterology report · doi:10.1093/gastro/goab040 · Cited by 21
“In 1,679 intensive care unit patients enrolled in the European Sepsis Occurrence in Acutely Ill Patients II trial, septic shock as the main part of distributive shock was the most frequent cause of shock, accounting for 62% of cases, followed by cardiogenic shock (17%) and hypovolemia (16%) [115].”
BackgroundTiming of Vasopressin Addition to Norepinephrine and Efficacy Outcomes in Patients With Septic Shock
Brask, A. L., Shemanski, S., Barnes, T. E., & Holmes, A. K. (2022) · Annals of Pharmacotherapy · doi:10.1177/10600280221118903 · Cited by 21
Circulatory shock in adults in emergency department
Pannu, A. K. (2023) · Turkish Journal of Emergency Medicine · doi:10.4103/2452-2473.367400 · Cited by 21
Sundermeyer, J., Kellner, C., Beer, B. N., Besch, L., Dettling, A., Bertoldi, L. F., Blankenberg, S., Dauw, J., Dindane, Z., Eckner, D., et al. (2023) · Clinical Research in Cardiology · doi:10.1007/s00392-023-02332-y · Cited by 21
“This study also demonstrated an increased risk of arrhythmias with dopamine use [32].”
BackgroundEarly management of adult sepsis and septic shock: Korean clinical practice guidelines
Park, C., Ku, N. S., Park, D. W., Park, J. H., Ha, T. S., Kim, D., Park, S. Y., Chang, Y., Jo, K.-W., Baek, M. S., et al. (2024) · Acute and Critical Care · doi:10.4266/acc.2024.00920 · Cited by 20
“In the analysis of three RCTs, the incidence of arrhythmia was significantly lower in the norepinephrine group than in the dopamine group (RR, 0.49; 95% CI, 0.40–0.59) [125-127].”
InfluentialBégot, E., Dalmay, F., Etchecopar, C., Clavel, M., Pichon, N., François, B., Lang, R. M., & Vignon, P. (2015) · Intensive Care Medicine · doi:10.1007/s00134-015-3998-4 · Cited by 21
“In patients with septic shock, the most common cause of circulatory failure in the ICU [4], TEE provides crucial information to aid the intensivist in the management of these unstable patients [5].”
BackgroundCoronary Revascularization in Cardiogenic Shock
Spence, N., & Abbott, J. D. (2015) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-015-0423-9 · Cited by 21
Control groups in recent septic shock trials: a systematic review
Pettilä, V., Hjortrup, P. B., Jakob, S. M., Wilkman, E., Perner, A., & Takala, J. A. (2016) · Intensive Care Medicine · doi:10.1007/s00134-016-4444-y · Cited by 21
Harrison, D. G., & Luther, J. M. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-2930-6.00006-9 · Cited by 21
Major publications in critical care pharmacotherapy literature in 2018
Sikora, A. N., Bissell, B. D., Burry, L. D., Defayette, A. A., Gagnon, D. J., Gilbert, B. W., Kramer, C. J., Miller, C. J., Semanco, M., Smith, M. N., et al. (2019) · Journal of Critical Care · doi:10.1016/j.jcrc.2019.04.029 · Cited by 21
Chen, C., Pang, L., Wang, Y., Wen, T., Yu, W., Yue, X., Rong, Y., & Liao, W. (2019) · Annals of Translational Medicine · doi:10.21037/atm.2019.09.134 · Cited by 21
Tehrani, B. N., Basir, M. B., & Kapur, N. K. (2020) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2020.09.001 · Cited by 21
Managing the first 120 min of cardiogenic shock: from resuscitation to diagnosis
Jentzer, J. C., Tabi, M., & Burstein, B. J. (2021) · Current Opinion in Critical Care · doi:10.1097/mcc.0000000000000839 · Cited by 21
Weiss, A., Dang, C., Mabrey, D., Stanton, M., Feih, J., Rein, L., & Feldman, R. (2021) · Shock · doi:10.1097/shk.0000000000001830 · Cited by 21
Vela, J. L. P., Benitez, J. C. M., González, M. C., López, M. Á. D. L. C., Pérez, R. H., Meneses, V. S., & Sáez, F. D. N. (2012) · Medicina Intensiva (English Edition) · doi:10.1016/j.medine.2012.01.007 · Cited by 21
Zimmerman, J. M., Lee, J. P., & Cahalan, M. K. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-48110-6.00025-9 · Cited by 21
Denault, A. Y., Vegas, A., & Royse, C. F. (2014) · Canadian Journal of Anesthesia/Journal canadien d anesthésie · doi:10.1007/s12630-014-0203-0 · Cited by 21
Inotropes and vasopressors: more than haemodynamics!
Bracht, H., Calzia, E., Georgieff, M., Singer, J., Radermacher, P., & Russell, J. A. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01776.x · Cited by 21
“…‘not all catecholamines are created equal’ (Carpati et al., 1997), and consequently, some catecholamines (noradrenaline) can be superior to others (dopamine, adrenaline), at least under specific conditions such as cardiogenic (De Backer et al., 2010) or septic (De Backer et al., 2003) shock.”
BackgroundVasopressor administration and sepsis: A survey of Canadian intensivists
Lamontagne, F., Cook, D. J., Adhikari, N. K. J., Briel, M., Duffett, M., Kho, M. E., Burns, K. E. A., Guyatt, G. H., Turgeon, A. F., Zhou, Q. X., et al. (2011) · Journal of Critical Care · doi:10.1016/j.jcrc.2011.01.005 · Cited by 21
“Although recent clinical trials provide some guidance regarding choice of vasopressor [9-12], there are few studies of self-reported or observed practices regarding vasopressor initiation and titration.”
BackgroundJiang, X., Du, S., Tian, Y., Su, W., Yang, D., & Zhao, H. (2016) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2015.0271 · Cited by 21
“De Backer et al. 18 reported that 40% of in-hospital deaths were caused by refractory shock despite fluid resuscitation.”
Becerra, A. F., Amanamba, U., Lopez, J. E., Blaker, N. J., & Winchester, D. E. (2025) · American Heart Journal Plus Cardiology Research and Practice · doi:10.1016/j.ahjo.2025.100524 · Cited by 20
Cardiogenic shock in Taiwan from 2003 to 2017 (CSiT-15 study)
Chien, S., Hsu, C., Liu, H., Lin, C., Hung, C., Huang, C., & Chien, L. (2021) · Critical Care · doi:10.1186/s13054-021-03820-1 · Cited by 20
“Trends in vasoactive agents and MCS Norepinephrine is the first-line medication for increasing blood and tissue perfusion pressure in patients with CS rather than dopamine or epinephrine [2, 21, 22].”
BackgroundObling, L. E. R., Beske, R. P., Meyer, M., Grand, J., Wiberg, S. C., Mohr, T. T., Damm-Hejmdal, A., Forman, J. L., Frikke‐Schmidt, R., Folke, F., et al. (2024) · Critical Care · doi:10.1186/s13054-024-04808-3 · Cited by 20
Acute Heart Failure and Non-Ischemic Cardiomyopathies: A Comprehensive Review and Critical Appraisal
Manzi, L., Buongiorno, F., Narciso, V., Florimonte, D., Forzano, I., Castiello, D. S., Sperandeo, L., Paolillo, R., Verde, N., Spinelli, A. M., et al. (2025) · Diagnostics · doi:10.3390/diagnostics15050540 · Cited by 20
“In a multicenter randomized trial that compared the use of dopamine and norepinephrine in the treatment of CS, out of a total of 1679 patients, only 44 patients had DCM [54], while in an open-label randomized trial of 85 patients admitted to the ICU for CS, eight had DCM [89].”
A Case Study in Intra-abdominal Sepsis
Paul, J. S., & Ridolfi, T. J. (2012) · Surgical Clinics of North America · doi:10.1016/j.suc.2012.08.014 · Cited by 20
Assessment and Management of Cardiogenic Shock in the Emergency Department
Klein, T., & Ramani, G. V. (2012) · Cardiology Clinics · doi:10.1016/j.ccl.2012.07.004 · Cited by 20
“In the subgroup of these patients with CS, norepinephrine was associated with reduced mortality, and dopamine with a higher arrhythmia burden.(49) Vasopressin and”
BackgroundUpdate on surgical sepsis syndrome
Vincent, J.-L. (2017) · British journal of surgery · doi:10.1002/bjs.10451 · Cited by 20
Self-citationThe role of vasopressin and the vasopressin type V1a receptor agonist selepressin in septic shock
Saad, A. F., & Maybauer, M. O. (2017) · Journal of Critical Care · doi:10.1016/j.jcrc.2017.03.008 · Cited by 20
“The authors also noted that the dopamine group had higher adverse events of dysrhythmias [17].”
BackgroundYao, R.-Q., Xia, D., Wang, L., Wu, G., Zhu, Y., Zhao, H., Liu, Q., Xia, Z., Ren, C., & Yao, Y.-M. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00563 · Cited by 20
Inotropic Agents and Vasopressors in the Treatment of Cardiogenic Shock
Shabana, A., Dholoo, F., & Banerjee, P. (2020) · Current Heart Failure Reports · doi:10.1007/s11897-020-00493-9 · Cited by 20
The Epidemiology of Extremity Threat and Amputation after Vasopressor-Dependent Sepsis
Reitz, K. M., Kennedy, J., Rieser, C. J., Hlavin, C., Gershengorn, H. B., Neal, M. D., Bensen, N., Linstrum, K., Prescott, H. C., Rosengart, M. R., et al. (2021) · Annals of the American Thoracic Society · doi:10.1513/annalsats.202105-547oc · Cited by 20
Rießen, R., Tschritter, O., Janssens, U., & Haap, M. M. (2015) · Medizinische Klinik - Intensivmedizin und Notfallmedizin · doi:10.1007/s00063-015-0011-5 · Cited by 20
Management of Cardiogenic Shock Unrelated to Acute Myocardial Infarction
Barnett, C. F., Brusca, S. B., Hanff, T. C., Blumer, V. L., Kalif, A., & Kanwar, M. K. (2023) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2023.01.023 · Cited by 20
Redfors, B., Shao, Y., Ali, A., Sun, B. H., & Ömerovic, E. (2014) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0000000000000088 · Cited by 20
Current Status of Inotropes in Heart Failure
Ginwalla, M. B., & Tofovic, D. S. (2018) · Heart Failure Clinics · doi:10.1016/j.hfc.2018.06.010 · Cited by 20
A Retrospective Review of Angiotensin II Use in Adult Patients With Refractory Distributive Shock
Wong, A., Alkazemi, A., Eche, I. M., Petri, C. R., Sarge, T., & Cocchi, M. N. (2019) · Journal of Intensive Care Medicine · doi:10.1177/0885066619872720 · Cited by 20
“Adverse effects of catecholamine vasopressors, such as dysrhythmias and ischemia, depend on the individual agent and can be dose dependent.(4) Addition of an alternative vasopressor with a different mechanism of action may allow for a reduction in catecholamine dosing, minimizing potential adverse effects.”
BackgroundToksvang, L. N., Plovsing, R. R., Petersen, M. W., Møller, K., & Berg, R. M. G. (2014) · Clinical Physiology and Functional Imaging · doi:10.1111/cpf.12120 · Cited by 20
Lin, J.-J., Chen, W., Ong, H., Hung, C., Chang, W., Huang, C., & Tsai, M. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13175293 · Cited by 19
“Etiologically, shock is classified into cardiogenic shock (CS), hypovolemic shock (HS), obstructive shock (OS), and distributive shock (DS) [1–5].”
BackgroundInfluentialLeisman, D. E., Wieruszewski, P. M., Busse, L. W., Chawla, L. S., Hibbert, K. A., Handisides, D. R., Khanna, A. K., Ostermann, M., McCurdy, M. T., Adams, C., et al. (2025) · Critical Care · doi:10.1186/s13054-025-05311-z · Cited by 19
Gelinas, J. P., & Russell, J. A. (2016) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2016.01.008 · Cited by 19
Costa, F., Sharif, S. Y., Bajamal, A. H., Shaikh, Y., Anania, C. D., & Zileli, M. (2021) · Neurospine · doi:10.14245/ns.2142518.259 · Cited by 19
Cardiotoxic Medication Poisoning
Cole, J. B., & Arens, A. M. (2022) · Emergency Medicine Clinics of North America · doi:10.1016/j.emc.2022.01.014 · Cited by 19
Li, Z., Pang, M., Li, Y., Yu, Y., Peng, T., Hu, Z., Niu, R., Li, J., & Wang, X. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.968615 · Cited by 19
“In a meta-analysis that included 2,768 patients in septic shock, the dopamine use resulted in a higher incidence of arrhythmic events and patient mortality than norepinephrine (51); the same conclusion was obtained in 1,679 patients in shock (52).”
ResultSepsis-Associated Acute Kidney Injury
Wang, D., Sun, T., & Liu, Z. (2023) · Intensive Care Research · doi:10.1007/s44231-023-00049-0 · Cited by 19
“Dopamine is not recommended for renoprotection and is associated with more adverse events than norepinephrine [74, 75].”
BackgroundKanter, J., & DeBlieux, P. M. C. (2014) · Emergency Medicine Clinics of North America · doi:10.1016/j.emc.2014.07.006 · Cited by 19
Comparative Effectiveness of Second Vasoactive Agents in Septic Shock Refractory to Norepinephrine
Nguyen, H. B., Lu, S. F., Possagnoli, I., & Stokes, P. (2016) · Journal of Intensive Care Medicine · doi:10.1177/0885066616647941 · Cited by 19
Poly(amido black) modified carbon paste electrode sensor for dopamine in the presence of uric acid
Shashikumara, J. K., Swamy, B. E. K., & Madhuchandra, H. D. (2020) · Materials Science for Energy Technologies · doi:10.1016/j.mset.2020.02.004 · Cited by 19
Fluid administration for acute circulatory dysfunction using basic monitoring
Messina, A., Collino, F., & Cecconi, M. (2020) · Annals of Translational Medicine · doi:10.21037/atm.2020.04.14 · Cited by 19
“source of hemodynamic instability starting from the most common: septic shock → cardiogenic shock → hypovolemic shock → distributive → obstructive (13).”
Rohm, C. L., Gadidov, B., Ray, H. E., Mannino, S. F., & Prasad, R. (2020) · Cardiovascular revascularization medicine · doi:10.1016/j.carrev.2020.12.001 · Cited by 19
Mechanical circulatory support in the treatment of cardiogenic shock
Fernando, S. M., Price, S., Mathew, R., Slutsky, A. S., Combes, A., & Brodie, D. (2022) · Current Opinion in Critical Care · doi:10.1097/mcc.0000000000000956 · Cited by 19
“Although norepinephrine appears to be the most effective vasopressor in cardiogenic shock [13,14], there are limited data supporting the use of any particular inotrope [15,16 && ], with the exception of levosimendan, which has shown some efficacy in patients with lower severity shock [17].”
BackgroundThe medical treatment of cardiogenic shock
Lescroart, M., Péquignot, B., Janah, D., & Lévy, B. (2023) · Journal of Intensive Medicine · doi:10.1016/j.jointm.2022.12.001 · Cited by 19
Sepsis, Severe Sepsis, and Septic Shock
Munford, R. S., & Suffredini, A. F. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-4801-3.00075-8 · Cited by 19
Cardiogenic shock: current epidemiology and management
Kataja, A., & Harjola, V. (2017) · Continuing Cardiology Education · doi:10.1002/cce2.62 · Cited by 19
Angiotensin II in Vasodilatory Shock
Wakefield, B. J., Busse, L. W., & Khanna, A. K. (2019) · Critical Care Clinics · doi:10.1016/j.ccc.2018.11.003 · Cited by 20
Intra-aortic balloon pump postcardiac surgery: A literature review
Jannati, M., & Attar, A. (2019) · Journal of Research in Medical Sciences · doi:10.4103/jrms.jrms_199_18 · Cited by 19
“[35,39] Different tools including IABP, percutaneous ventricular assist device (pVAD), and extracorporeal life support (ECLS) have been introduced as common tools for CS recovery.”
Roger C. Bone, MD and the Evolving Paradigms of Sepsis
BALK, R. A. (2011) · Contributions to microbiology · doi:10.1159/000323970 · Cited by 19
L’Hermite, S., Coirier, V., & Artru, F. (2025) · Transplant International · doi:10.3389/ti.2025.14752 · Cited by 18
Contemporary Management of Cardiogenic Shock Complicating Acute Myocardial Infarction
Luca, L. D., Mistrulli, R., Scirpa, R., Thiele, H., & Luca, G. D. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12062184 · Cited by 18
Perioperative Point of Care Ultrasound for Hemodynamic Assessment: A Narrative Review
Bradley, C. A., Ma, C., & Hollon, M. (2023) · Seminars in Cardiothoracic and Vascular Anesthesia · doi:10.1177/10892532231165088 · Cited by 18
“In the ICU, distributive shock is the most common type of shock encountered, with septic shock most frequently the cause.(33) With a combination of echocardiographic calculations and non-invasive or invasive hemodynamic measurements, systemic vascular resistance (SVR) can be derived via the following equation: SVR = 8…”
Trajectory of PaO 2 /FiO 2 Ratio in Shock After Angiotensin II
Wieruszewski, P. M., Coleman, P. J., Levine, A. R., Davison, D. L., Smischney, N. J., Kethireddy, S., Guo, Y., Hecht, J. P., Mazzeffi, M. A., & Chow, J. H. (2023) · Journal of Intensive Care Medicine · doi:10.1177/08850666231174870 · Cited by 18
Fillable Magnetic Microrobots for Drug Delivery to Cardiac Tissues In Vitro
Chen, M. S., Sun, R., Wang, R., Zuo, Y., Zhou, K., Kim, J., & Stevens, M. M. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202400419 · Cited by 18
Safe Use of Vasopressin and Angiotensin II for Patients with Circulatory Shock
Bauer, S. R., Sacha, G. L., & Lam, S. W. (2018) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2147 · Cited by 18
“In addition, even though NE is a b1 agonist, when it is initiated for patients with shock, HR typically decreases.(44) As such, the mechanism of the HR findings from ATHOS-3 should be further investigated.”
BackgroundJha, A., Zilahi, G., & Rhodes, A. (2021) · BJA Education · doi:10.1016/j.bjae.2021.03.002 · Cited by 18
Vasoactive pharmacologic therapy in cardiogenic shock: a critical review
Kaddoura, R., Elmoheen, A. M., Badawy, E., Eltawagny, M., Seif, M. A., Bashir, K., & Salam, A. M. (2021) · Journal of Drug Assessment · doi:10.1080/21556660.2021.1930548 · Cited by 18
“[69] 1 0 1 2 1 0 1 AC: no ITT: unclear SS: no 4”
Lim, J. Y., Park, S. J., Kim, H. J., Kim, H. J., Choo, S. J., Chung, C. H., Lee, J. W., Park, D., & Kim, J. B. (2021) · Journal of Cardiac Surgery · doi:10.1111/jocs.15861 · Cited by 18
“Recently, a randomized clinical trial (RCT) comparing dopamine and norepinephrine to manage shock reported that dopamine was associated with more arrhythmic events even though there was no significant difference in the rate of death between groups in a total cohort.(7) Furthermore, dopamine was associated with a highe…”
BackgroundMethodInfluentialKaddoura, R., & Elbdri, S. (2021) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2203078 · Cited by 18
Management of Decompensated Cirrhosis and Associated Syndromes
Chandna, S., Zarate, E. A. R., & Gallegos-Orozco, J. F. (2021) · Surgical Clinics of North America · doi:10.1016/j.suc.2021.09.005 · Cited by 18
Metadata
- Authors
- De Backer, D., Biston, P., Devriendt, J., Madl, C., Chochrad, D., Aldecoa, C., Brasseur, A., Defrance, P., Gottignies, P., & Vincent, J.-L.
- Affiliations
- Université Libre de Bruxelles (BE)
- Medical University of Vienna (AT)
- Centre hospitalier Etterbeek-Ixelles (BE)
- Erasmus Hospital (BE)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2010-03-04
- Volume
- 362
- Issue
- 9
- Pages
- 779-789
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2095944485
- Cited by
- 1,940
- References
- 31
- Citations by year
- 2026: 98 · 2025: 107 · 2024: 140 · 2023: 115 · 2022: 125 · 2021: 132 · 2020: 135 · 2019: 138 · 2018: 106 · 2017: 139 · 2016: 99 · 2015: 122 · 2014: 120 · 2013: 96 · 2012: 110
- FWCI
- 83.32
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion)
- Topics
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Health Sciences › Medicine › Surgery › Hemodynamic Monitoring and Therapy
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Trauma, Hemostasis, Coagulopathy, Resuscitation
- Keywords
- dopamine, norepinephrine, vasopressors, shock, cardiogenic shock, septic shock, hypovolemic shock, 28-day mortality, cardiac arrhythmias, epinephrine, vasopressin, organ support, adverse events, subgroup analysis, vasopressor weaning
- MeSH terms
- Aged, Arrhythmias, Cardiac, Combined Modality Therapy, Dopamine, Female, Fluid Therapy, Humans, Male, Middle Aged, Norepinephrine, Shock, Vasoconstrictor Agents, Kaplan-Meier Estimate, Intention to Treat Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.